VBI Operating Income from 2010 to 2024
VBIV Stock | USD 0.59 0.02 3.28% |
Operating Income | First Reported 1997-06-30 | Previous Quarter -12.4 M | Current Value -12.4 M | Quarterly Volatility 7.2 M |
Check VBI Vaccines financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VBI main balance sheet or income statement drivers, such as Interest Expense of 8.5 M, Selling General Administrative of 44.3 M or Total Revenue of 9.1 M, as well as many exotic indicators such as Price To Sales Ratio of 1.0, Dividend Yield of 0.0 or PTB Ratio of 0.66. VBI financial statements analysis is a perfect complement when working with VBI Vaccines Valuation or Volatility modules.
VBI | Operating Income |
Latest VBI Vaccines' Operating Income Growth Pattern
Below is the plot of the Operating Income of VBI Vaccines over the last few years. Operating Income is the amount of profit realized from VBI Vaccines operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of VBI Vaccines is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. VBI Vaccines' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VBI Vaccines' overall financial position and show how it may be relating to other accounts over time.
Operating Income | 10 Years Trend |
|
Operating Income |
Timeline |
VBI Operating Income Regression Statistics
Arithmetic Mean | (35,224,609) | |
Coefficient Of Variation | (73.89) | |
Mean Deviation | 22,615,410 | |
Median | (37,280,000) | |
Standard Deviation | 26,027,495 | |
Sample Variance | 677.4T | |
Range | 81.6M | |
R-Value | (0.87) | |
Mean Square Error | 178.4T | |
R-Squared | 0.76 | |
Significance | 0.000026 | |
Slope | (5,058,701) | |
Total Sum of Squares | 9484T |
VBI Operating Income History
Other Fundumenentals of VBI Vaccines
VBI Vaccines Operating Income component correlations
Click cells to compare fundamentals
About VBI Vaccines Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include VBI Vaccines income statement, its balance sheet, and the statement of cash flows. VBI Vaccines investors use historical funamental indicators, such as VBI Vaccines's Operating Income, to determine how well the company is positioned to perform in the future. Although VBI Vaccines investors may use each financial statement separately, they are all related. The changes in VBI Vaccines's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VBI Vaccines's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on VBI Vaccines Financial Statements. Understanding these patterns can help to make the right decision on long term investment in VBI Vaccines. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Operating Income | -55.3 M | -52.5 M | |
Non Operating Income Net Other | -24.7 M | -23.5 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VBI Vaccines in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VBI Vaccines' short interest history, or implied volatility extrapolated from VBI Vaccines options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:Check out the analysis of VBI Vaccines Correlation against competitors. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Revenue Per Share 0.558 | Quarterly Revenue Growth 1.911 | Return On Assets (0.29) | Return On Equity (2.59) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.